• Enterprise value to EBIT forward of Gain Therapeutics, Inc. – NASDAQ:GANX TradingView Sat, 04 Jul 2026 15:25:41 GMT
• enterprise value to revenue forward of gain therapeutics, inc. – nasdaq:ganx TradingView Sat, 04 Jul 2026 07:45:12 GMT
• Maxim Group Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $7 Moomoo Thu, 02 Jul 2026 19:31:00 GMT
• gain therapeutics: buy rating reaffirmed on gt-02287 clinical momentum and differentiated gcase strategy; $7 price target unchange... TipRanks Thu, 02 Jul 2026 18:49:52 GMT
• Roth MKM Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $8 富途牛牛 Wed, 01 Jul 2026 17:31:00 GMT
• GANX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $8.00 GuruFocus Wed, 01 Jul 2026 13:45:22 GMT
• gain therapeutics buy rating reiterated as fda clears gt-02287 phase 2; 12-month $8 price target maintained TipRanks Wed, 01 Jul 2026 12:06:16 GMT
• H.C. Wainwright Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $8 富途牛牛 Wed, 01 Jul 2026 10:31:00 GMT
• H.C. Wainwright reiterates Gain Therapeutics stock rating on FDA approval Investing.com Wed, 01 Jul 2026 07:00:00 GMT
• price to sales forward of gain therapeutics, inc. – nasdaq:ganx TradingView Tue, 30 Jun 2026 08:01:52 GMT
• number of shareholders of gain therapeutics, inc. – nasdaq:ganx TradingView Tue, 30 Jun 2026 04:40:53 GMT
• gain therapeutics receives fda clearance to initiate phase 2 trial of gt-02287 for parkinson’s disease Minichart Tue, 30 Jun 2026 01:51:00 GMT
• stocks to watch: aerovironment, concentrix, gain therapeutics, praxis precision medicines Moomoo Mon, 29 Jun 2026 22:50:00 GMT
• gain therapeutics (ganx) jumps 13% to $1.98 – support and resistance levels in focus - elliott wave entry dars.gov.et Mon, 29 Jun 2026 22:32:32 GMT
• gain therapeutics advances gt-02287 into phase 2 parkinson’s trial TipRanks Mon, 29 Jun 2026 21:12:18 GMT
• gain therapeutics gets us fda approval to advance gt-02287 into phase 2 study for parkinson's disease marketscreener.com Mon, 29 Jun 2026 20:49:58 GMT
• Gain Therapeutics stock surges on FDA clearance for Parkinson’s drug Investing.com Mon, 29 Jun 2026 20:39:34 GMT
• gain therapeutics receives fda clearance of gt-02287 ind application TipRanks Mon, 29 Jun 2026 20:39:19 GMT
• price to earnings forward of gain therapeutics, inc. – nasdaq:ganx TradingView Mon, 29 Jun 2026 15:51:45 GMT
• price to book forward of gain therapeutics, inc. – nasdaq:ganx TradingView Mon, 29 Jun 2026 13:31:48 GMT
• FDA clears Gain Therapeutics drug GT-02287 for Phase 2 Parkinson’s trial Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease BioBuzz Mon, 29 Jun 2026 07:00:00 GMT
• Gain Therapeutics receives FDA clearance for Parkinson’s drug trial Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• Gain Therapeutics (GANX) wins FDA IND clearance to start GT-02287 Phase 2 Parkinson’s trial Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• 12 Health Care Stocks Moving In Monday's After-Market Session Benzinga Mon, 29 Jun 2026 07:00:00 GMT
• FDA clears Gain Therapeutics' IND for GT-02287, advancing Parkinson's drug to Phase 2 trials in 3Q26 Pluang Mon, 29 Jun 2026 07:00:00 GMT
• 3 Clinical-Stage Biotech Stocks Worth Watching In Parkinson's Research simplywall.st Fri, 26 Jun 2026 07:00:00 GMT
• gain therapeutics inc (ganx) valuation: pe, pb & fair value analysis TradingKey Fri, 26 Jun 2026 07:00:00 GMT
• gain therapeutics, inc. announces 2026 shareholder vote results and emerging growth company status (ganx) Minichart Fri, 26 Jun 2026 01:59:00 GMT
• gain therapeutics, inc. actuals & estimates (nasdaq:ganx) TradingView Thu, 25 Jun 2026 22:06:27 GMT
• gain therapeutics shareholders confirm board and auditor choices TipRanks Thu, 25 Jun 2026 21:52:49 GMT
• Gain Therapeutics (GANX) shareholders back board slate and Ernst & Young AG at 2026 meeting Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• 3 Clinical-Stage Biotech Stocks Worth Watching In Parkinson's Research Sahm Thu, 25 Jun 2026 07:00:00 GMT
• gain therapeutics inc (ganx) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• gain therapeutics inc (ganx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• gain therapeutics inc (ganx) financial health: profitability & balance sheet analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• gain therapeutics inc (ganx) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• gain therapeutics inc (ganx) risk assessment: volatility, financial risk & investment risk TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• gain therapeutics inc (ganx) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 02:46:33 GMT
• gain therapeutics inc (ganx) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 02:30:30 GMT
• gain therapeutics inc (ganx) earnings forecast: future eps & revenue growth estimates TradingKey Fri, 19 Jun 2026 02:20:46 GMT
• gain therapeutics inc (ganx) financial health: profitability & balance sheet analysis TradingKey Fri, 19 Jun 2026 01:16:10 GMT
• gain therapeutics inc (ganx) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 19 Jun 2026 00:00:24 GMT
• gain therapeutics inc (ganx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 11:22:30 GMT
• Gain Therapeutics Inc (GANX) Shareholder Structure: Major Shareholders & Institutional Holdings TradingKey Thu, 18 Jun 2026 11:20:27 GMT
• gain therapeutics inc (ganx) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• gain therapeutics inc. (ganx) q1 2026 earnings: narrower-than-expected loss fails to lift shares - revenue guidance range newsline.com Sun, 14 Jun 2026 10:34:45 GMT
• Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• biotech gain therapeutics joins h.c. wainwright neuro expert summit Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• bial ends development of parkinson’s disease drug after phase iib fail Citeline News & Insights Tue, 09 Jun 2026 22:10:18 GMT
• Gain Therapeutics (GANX) Receives a Buy from H.C. Wainwright The Globe and Mail Tue, 09 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $8 富途牛牛 Tue, 09 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains gain therapeutics(ganx.us) with buy rating, maintains target price $8 Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• gain therapeutics (ganx) price target increased by 11.76% to 7.75 MSN Fri, 05 Jun 2026 18:36:56 GMT
• GANX Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Biotech Advances Parkinson’s Program dars.gov.et Tue, 02 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains gain therapeutics(ganx.us) with buy rating, maintains target price $8 Moomoo Fri, 29 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: gain therapeutics (ganx) and travere therapeutics (tvtx) The Globe and Mail Fri, 29 May 2026 07:00:00 GMT
• h.c. wainwright maintains gain therapeutics(ganx.us) with buy rating, maintains target price $8 Moomoo Thu, 28 May 2026 07:00:00 GMT
• Gain Therapeutics stock maintained at Outperform by Oppenheimer Investing.com Wed, 27 May 2026 07:00:00 GMT
• roth mkm maintains gain therapeutics(ganx.us) with buy rating, maintains target price $8 Moomoo Wed, 27 May 2026 07:00:00 GMT
• gain therapeutics expands ‘compelling’ evidence base for parkinson’s candidate Yahoo Finance Wed, 27 May 2026 04:34:00 GMT
• gain therapeutics presents data from phase 1b study of gt-02287 TipRanks Tue, 26 May 2026 22:58:50 GMT
• gain therapeutics releases first quarter 2026 financial results and corporate update geneonline.com Tue, 26 May 2026 21:40:42 GMT
• gain therapeutics announces interim clinical and biomarker data from phase 1b study of gt-02287 in parkinson's disease marketscreener.com Tue, 26 May 2026 15:38:09 GMT
• gain therapeutics reports encouraging phase 1b nine-month data for gt-02287 in parkinson’s patients TradingView Tue, 26 May 2026 13:33:01 GMT
• gain therapeutics says mds-updrs scores remain stable after 150 days of gt-2287 treatment marketscreener.com Tue, 26 May 2026 12:58:28 GMT
• Gain Therapeutics expands ‘compelling’ evidence base for Parkinson’s candidate Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026 Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• Gain Therapeutics Inc. Q1 2026 Earnings: EPS Surprise Highlights Cost Discipline Amid Pre-Revenue Stage dars.gov.et Tue, 26 May 2026 07:00:00 GMT
• parkinson’s patients report better smell, sleep, balance on experimental gt-02287 Stock Titan Tue, 26 May 2026 07:00:00 GMT
• gain therapeutics presents phase 1b data on parkinson’s drug Investing.com Tue, 26 May 2026 07:00:00 GMT
• gt-02287 shows biomarker, symptom stability in gain (ganx) parkinson’s study Stock Titan Tue, 26 May 2026 07:00:00 GMT
• gain therapeutics reports interim data for parkinson’s candidate TipRanks Tue, 26 May 2026 07:00:00 GMT
• btig maintains gain therapeutics(ganx.us) with buy rating, maintains target price $5 Moomoo Tue, 26 May 2026 07:00:00 GMT
• bial announces completion of phase 2b activate study with bia 28-6156 in gba1-associated parkinson’s Yahoo Finance Tue, 26 May 2026 06:00:00 GMT
• gain therapeutics (ganx) bounces back: testing key resistance at $1.87 - equal weight etf newsline.com Mon, 25 May 2026 07:00:00 GMT
• gain therapeutics inc. (ganx) q1 2026 earnings: narrower loss surpasses estimates, stock edges higher - earnings yield spread newsline.com Sat, 23 May 2026 07:00:00 GMT
• 3 parkinson's biotech stocks analysts think are wildly mispriced simplywall.st Fri, 22 May 2026 07:00:00 GMT
• gain therapeutics (ganx) edges higher as shares approach key resistance level - pcr extreme newsline.com Fri, 22 May 2026 07:00:00 GMT
• gain therapeutics (ganx) edges higher as biotech sector shows mixed signals - ad line divergence The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• 3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced Yahoo Finance Thu, 21 May 2026 07:00:00 GMT
• gain therapeutics (ganx) q1 2026 earnings beat: revenue $n/a, eps $-0.13 - revenue growth outlook newsline.com Tue, 19 May 2026 07:00:00 GMT
• roth mkm maintains gain therapeutics(ganx.us) with buy rating, cuts target price to $8 富途牛牛 Tue, 19 May 2026 00:39:35 GMT
• gain therapeutics (ganx) shares edge higher after narrower-than-expected q1 loss MSN Mon, 18 May 2026 13:56:37 GMT
• ganx technical analysis | trend, signals & chart patterns | gain therapeutics inc (nasdaq:ganx) ChartMill Mon, 18 May 2026 07:00:00 GMT
• ganx gain therapeutics eps beats by 26 but shares decline 27 amid revenue concerns - performance review newsline.com Sun, 17 May 2026 07:00:00 GMT
• gain therapeutics (ganx) shares edge higher after narrower-than-expected q1 loss MSN Sat, 16 May 2026 19:45:27 GMT
• maxim group maintains gain therapeutics(ganx.us) with buy rating, maintains target price $7 Moomoo Thu, 14 May 2026 07:00:00 GMT
• gain therapeutics (ganx) gets a buy from oppenheimer The Globe and Mail Thu, 14 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: dyne therapeutics (dyn), health catalyst (hcat) and gain therapeutics (ganx) The Globe and Mail Wed, 13 May 2026 07:00:00 GMT
• roth mkm maintains gain therapeutics(ganx.us) with buy rating, cuts target price to $8 Moomoo Tue, 12 May 2026 11:32:00 GMT
• gain therapeutics reports financial results for first quarter 2026 and provides corporate update Black Hills Pioneer Tue, 12 May 2026 09:00:00 GMT
• gain therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 20:09:00 GMT
• gain therapeutics (nasdaq:ganx) releases quarterly earnings results, hits expectations MarketBeat Mon, 11 May 2026 17:33:41 GMT
• gain therapeutics: remain on track to begin our phase 2 study in 3q 2026 >ganx Moomoo Mon, 11 May 2026 11:08:00 GMT
• Gain Therapeutics (GANX) Shares Edge Higher After Narrower-Than-Expected Q1 Loss Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• gain parkinson’s trial sees 81% biomarker drop, phase 2 planned Stock Titan Mon, 11 May 2026 07:00:00 GMT
• gain therapeutics (nasdaq: ganx) details q1 2026 loss and parkinson’s trial plans Stock Titan Mon, 11 May 2026 07:00:00 GMT
• gain therapeutics beats q1 loss estimates, shares rise 3% by investing.com Investing.com South Africa Mon, 11 May 2026 07:00:00 GMT
• gain therapeutics: expect to receive fda clearance of our gt-02287 ind during 2q 2026 >ganx Moomoo Mon, 11 May 2026 07:00:00 GMT
• gain therapeutics reports q1 2026 net loss $5.61m; cash $16.5m; r&d and g&a rise TradingView Mon, 11 May 2026 07:00:00 GMT
• gain therapeutics (nasdaq: ganx) posts higher q1 2026 loss and flags going concern risk Stock Titan Mon, 11 May 2026 07:00:00 GMT
• design therapeutics, inc. (dsgn) is up 6.92% in one week: what you should know Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• gain therapeutics inc expected to post a loss of 14 cents a share - earnings preview TradingView Fri, 08 May 2026 15:30:48 GMT
• gain therapeutics, inc. (nasdaq:ganx) given average recommendation of "moderate buy" by analysts MarketBeat Thu, 07 May 2026 06:53:41 GMT
• Protein degraders gain speed as Arvinas scores landmark approval Pharma Voice Mon, 04 May 2026 07:00:00 GMT
• [def 14a] gain therapeutics, inc. definitive proxy statement Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• ganx technical analysis | trend, signals & chart patterns | gain therapeutics inc (nasdaq:ganx) ChartMill Tue, 28 Apr 2026 07:00:00 GMT
• gain therapeutics announces oral presentation at 3rd international gba1 meeting 2026 marketscreener.com Mon, 27 Apr 2026 11:03:17 GMT
• maxim group maintains gain therapeutics(ganx.us) with buy rating, maintains target price $7 富途牛牛 Sat, 25 Apr 2026 20:30:01 GMT
• h.c. wainwright maintains gain therapeutics(ganx.us) with buy rating, maintains target price $8 富途牛牛 Sat, 25 Apr 2026 13:06:11 GMT
• Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026 Yahoo Finance Fri, 24 Apr 2026 07:00:00 GMT
• gain to present parkinson’s drug update at phoenix gba1 meeting Stock Titan Fri, 24 Apr 2026 07:00:00 GMT
• gain therapeutics, inc. to present update on parkinson’s disease drug gt-02287 at 3rd international gba1 meeting 2026 Quiver Quantitative Fri, 24 Apr 2026 07:00:00 GMT
• ganx gain therapeutics posts narrower q4 2025 loss than estimates, but shares fall 2.39%. - earnings call q&a newsline.com Thu, 23 Apr 2026 07:00:00 GMT
• ganx gain therapeutics posts narrower q4 2025 loss than estimates, but shares fall 2.39%. - liquidity risk Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 23:49:18 GMT
• we're hopeful that infant bacterial therapeutics (sto:ibt b) will use its cash wisely simplywall.st Mon, 20 Apr 2026 07:00:00 GMT
• assessing tg therapeutics (tgtx) valuation after briumvi phase 3 subcutaneous trial milestone simplywall.st Mon, 20 Apr 2026 07:00:00 GMT
• will fda fast track for kt-621 and gilead’s kt-200 deal change kymera therapeutics' (kymr) narrative simplywall.st Sun, 19 Apr 2026 23:16:38 GMT
• assessing viking therapeutics (vktx) valuation after strong multi‑year share price gains simplywall.st Sat, 18 Apr 2026 07:00:00 GMT
• ganx | gain therapeutics, inc. common insider trading Quiver Quantitative Fri, 17 Apr 2026 06:43:50 GMT
• with silence therapeutics up 24%, insider buyers count their returns simplywall.st Thu, 16 Apr 2026 07:00:00 GMT
• cardinal health report highlights community therapies and raises new investor questions simplywall.st Wed, 15 Apr 2026 07:00:00 GMT
• breakout watch: does gain therapeutics inc have a sustainable dividend - market risk analysis & fast exit and entry trade guides baoquankhu1.vn Mon, 13 Apr 2026 09:02:33 GMT
• gain therapeutics, inc. (nasdaq:ganx) receives consensus recommendation of "moderate buy" from analysts MarketBeat Sun, 12 Apr 2026 07:00:00 GMT
• sharp therapeutics' '901 ind preparation: breakthrough moment or just buzz? bitget.com Fri, 10 Apr 2026 06:39:50 GMT
• technical analysis: will gain therapeutics inc benefit from green energy policies - quarterly trade review & free risk controlled ... baoquankhu1.vn Fri, 10 Apr 2026 03:13:04 GMT
• ganx technical analysis | trend, signals & chart patterns | gain therapeutics inc (nasdaq:ganx) ChartMill Wed, 08 Apr 2026 07:00:00 GMT
Gain Therapeutics, Inc(NASDAQ:GANX) 
Gain Therapeutics, Inc. is a redefining drug discovery company with its proprietary target identification platform. It focuses on identifying and optimizing allosteric binding sites and is unlocking new treatment options for disorders characterized by protein misfolding. The company was founded in 2...
Share this website to your friends